Causes of IgA-Mediated Peripheral Neuropathy
The association between IgA monoclonal gammopathy and peripheral neuropathy is less clear than with IgM, and the IgA M-protein may often be an incidental finding without direct causal relationship to the neuropathy 1.
Primary Underlying Mechanisms
When IgA monoclonal gammopathy does cause peripheral neuropathy, the mechanisms include:
1. Monoclonal Gammopathy of Undetermined Significance (MGUS)
- IgA MGUS can be associated with peripheral neuropathy, though this occurs less frequently than with IgM MGUS 1
- The pathogenic role remains unclear in many cases, as the M-protein may lack demonstrable autoantibody activity 2
- When causally related, IgA deposits may be found in the myelin sheath 3
2. POEMS Syndrome
- This is a critical diagnosis not to miss: Polyneuropathy, Organomegaly, Endocrinopathy, M-protein (mainly IgG-λ and IgA-λ), sclerotic bone changes, and skin changes 1
- VEGF levels are markedly elevated and correlate with disease activity
- The pathogenesis involves both M-protein effects and growth factors produced by the underlying plasma cell clone
3. AL Amyloidosis
- This is a life-threatening cause that requires urgent recognition: Misfolded immunoglobulin light-chains deposit as amyloid fibrils in tissues 1
- Neurological manifestations include sensorimotor neuropathy and autonomic neuropathy
- IgA monoclonal gammopathy with neuropathy may be a harbinger of AL amyloidosis 4
- Red flags for malignant transformation include: abnormal serum free light chain ratio, rapidly progressive debilitating neuropathy refractory to immunotherapy, prominent autonomic dysfunction, and weight loss 4
4. Cryoglobulinemia
- Type I cryoglobulinemia can occur with IgA monoclonal proteins (though IgM and IgG are more typical) 1
- Peripheral neuropathy occurs alongside other manifestations like Raynaud phenomenon, renal failure, and skin vasculitis
5. Multiple Myeloma
- IgA or IgG monoclonal gammopathies may be associated with malignant myeloma 5
- The neuropathy may result from direct effects of the malignant plasma cell dyscrasia
Clinical Patterns of IgA-Associated Neuropathy
The spectrum is heterogeneous 6:
Demyelinating Pattern (60% of cases)
- Chronic progressive or relapsing demyelinating polyneuropathy clinically indistinguishable from chronic inflammatory demyelinating polyneuropathy (CIDP) 6
- More heterogeneous demyelinating pattern than IgM-associated neuropathy
- Frequently responds to immunosuppressive treatments, supporting a dysimmune process 6
Axonal Pattern (40% of cases)
- Chronic axonal distal polyneuropathy similar to cryptogenic sensory polyneuropathy 6
- Less clear relationship with the M-protein
- Poor response to immunosuppressive treatments 6
Critical Diagnostic Pitfall
The major clinical caveat is distinguishing true causation from coincidental association. IgA monoclonal gammopathy occurs in approximately 1% of the normal adult population 7, so its presence does not automatically implicate it as the cause of neuropathy. Unlike IgM M-proteins, IgA M-proteins less frequently demonstrate autoantibody activity against specific neural antigens 7, 2.
When to Suspect Causal Relationship
Consider IgA M-protein as causally related when:
- Demyelinating pattern resembling CIDP is present
- No other cause of neuropathy is identified
- Response to immunotherapy targeting the plasma cell clone occurs
- Evidence of POEMS syndrome, AL amyloidosis, or cryoglobulinemia exists
- Progressive, severe neuropathy with autonomic involvement and systemic symptoms suggests malignant transformation 4